Morphologic, Clinical and Molecular Features of Large Cell Neuroendocrine Carcinoma (LCNEC) of the Bladder

被引：0

作者：

Mirsadraei, Leili ^{[1
]}

Hao, Xueli ^{[1
]}

Teo, Min-Yuen ^{[1
]}

Huang, Kuo-Cheng ^{[1
]}

Chen, Ying-Bei ^{[1
]}

Gopalan, Anuradha ^{[1
]}

Sirintrapun, Joe ^{[1
]}

Fine, Samson W. ^{[1
]}

Tickoo, Satish K. ^{[1
]}

Bochner, Bernard H. ^{[1
]}

Dalbagni, Guido ^{[1
]}

Bajorin, Dean F. ^{[1
]}

Taylor, Barry S. ^{[1
]}

Solit, David ^{[1
]}

Iyer, Gopakumar V. ^{[1
]}

Reuter, Victor E. ^{[1
]}

Al-Ahmadie, Hikmat ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

LABORATORY INVESTIGATION | 2017年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

985

引用

页码：244A / 244A

页数：1

共 50 条

[41] Large-cell neuroendocrine carcinoma (LCNEC): a review of experience with adjuvant chemotherapy at Wythenshawe Hospital
Khan, S. Leyakathali
Peck, R.
Bishop, P.
Califano, R.
Summers, Y.
Taylor, P.
[J]. LUNG CANCER, 2013, 79 : S16 - S17
[42] LARGE CELL CARCINOMA [LCC] (CLASSICAL, LCC WITH NEUROENDOCRINE MORPHOLOGY [LCCNM], AND LARGE CELL NEUROENDOCRINE CARCINOMA [LCNEC]) AND SMALL CELL CARCINOMA [SCC] OF THE LUNG: SHOULD THEY BE TREATED EQUALLY IN ADVANCED STAGES?
Dettino, Aldo L. A.
Molin, Graziella Z. D.
Nicolau, Ulisses R.
Lima, Vladmir C. C. D.
Tariki, Milena S.
Freitas, Helano C.
Fanelli, Marcello F.
Haddad, Fabio J.
Rozenowicz, Renato D. L.
Baranauskas, Marcus Vinicius B.
Osorio, Cynthia T.
Pinto, Clovis A. L.
Gross, Jefferson L.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S120 - S121
[43] Prognostic Significance of YAP1 and Its Association with Neuroendocrine Markers in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNEC)
Sun, X.
Dong, J.
Liu, L.
Xing, P.
Yang, L.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S516 - S516
[44] Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma
Chen, Ying
Cui, Xiaoying
Wang, Di
Xia, Guojie
Xing, Minyan
Cheng, Lei
Sheng, Liming
Du, Xianghui
[J]. FRONTIERS IN ONCOLOGY, 2022, 11
[45] Prevalence and Prognostic Value of PD-L1 Expression in Molecular Subtypes of Metastatic Large Cell Neuroendocrine Carcinoma (LCNEC)
Hermans, B.
Derks, J. L.
Thunnissen, E.
Van Suylen, R. J.
Den Bakker, M. A.
Groen, H. J. M.
Smit, E. F.
Damhuis, R. A.
Van den Broek, E. C.
Dingemans, A. M. C.
Speel, E. J. M.
[J]. NEUROENDOCRINOLOGY, 2019, 108 : 171 - 171
[46] Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)
Hermans, B. C. M.
Derks, J. L.
Thunissen, E.
van Suylen, R. J.
den Bakker, M. A.
Groen, H. J. M.
Smit, E. F.
Damhuis, R. A.
van den Broek, E. C.
Stallinga, C. M.
Roemen, G. M.
Speel, E. J.
Dingemans, A-M. C.
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 643 - 643
[47] Urinary Cytologic Features of Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder A Case Report
Oshiro, Hisashi
Gomi, Kiyoshi
Nagahama, Kiyotaka
Nagashima, Yoji
Kanazawa, Michiyo
Kato, Junji
Hatano, Takashi
Inayama, Yoshiaki
[J]. ACTA CYTOLOGICA, 2010, 54 (03) : 303 - 310
[48] CLEAR CELL ENDOMETRIAL CARCINOMA (CLINICAL AND MORPHOLOGIC FEATURES)
Ulrikh, E.
Khalimbekova, D.
Matzcko, D.
Merabishvili, V.
Sidoruk, A.
Urmancheeva, A.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
[49] Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features
Iyoda, A
Hiroshima, K
Toyozaki, T
Haga, Y
Baba, M
Fujisawa, T
Ohwada, H
[J]. CANCER, 2001, 92 (05) : 1108 - 1112
[50] Clinicopathologic Features of Large Cell Neuroendocrine Carcinoma of Lung
Arikan, R.
Demircan, N.
Basoglu, T.
Telli, T. Akin
Ercelep, O.
Dane, F.
Yumuk, P. F.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S498 - S499

← 1 2 3 4 5 →